The endocannabinoid system is involved in the anxiety-like behavior induced by dual-frequency 2.65/0.8 GHz electromagnetic radiation in mice

Overview

With the widespread use of wireless communication devices, concerns are rising over the mental health risks posed by environmental exposure to complex frequency electromagnetic radiation (EMR). Prior studies have primarily targeted single-frequency EMR, underrepresenting more realistic, multi-frequency exposures found in modern environments.

Study Goals

• Compare emotional effects of single-frequency versus dual-frequency EMR
• Investigate molecular mechanisms underlying EMR effects
• Explore intervention targets for mitigating EMR-induced anxiety

Findings

• Single-frequency EMR at 2.65 or 0.8 GHz did not trigger anxiety-like behavior in mice.
• Exposure to dual-frequency 2.65/0.8 GHz EMR significantly induced anxiety-like behavior in mice.
• Mouse serum analysis showed substantial increases in corticosterone and corticotrophin releasing hormone after dual-frequency exposure.
• Transcriptome and western blot analyses revealed a marked decrease in Cnr1 (CB1R) and CB1R content, implicating the endocannabinoid system.
• The endocannabinoid 2-arachidonoylglycerol was notably decreased in cerebral cortex tissue.
• Administration of the cannabinoid receptor agonist Win55-212-2 mitigated anxiety-like behavior, while the CB1R antagonist AM251 reversed this effect.

Conclusion

This research demonstrated that dual-frequency EMR exposure is much more likely to induce anxiety-like behavior in mice than single-frequency exposure. There are clear impacts on the hypothalamic-pituitary-adrenal axis and the endocannabinoid system. The findings point to cannabinoids as a potential avenue for anti-EMR drug development. These results highlight the potential health risks associated with EMF exposure, especially from multiple simultaneous frequencies, which are increasingly common in modern environments.